These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32160715)

  • 21. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
    Kun-Peng Z; Chun-Lin Z; Xiao-Long M
    Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly enriched exosomal lncRNA OIP5-AS1 regulates osteosarcoma tumor angiogenesis and autophagy through miR-153 and ATG5.
    Li Y; Lin S; Xie X; Zhu H; Fan T; Wang S
    Am J Transl Res; 2021; 13(5):4211-4223. PubMed ID: 34150009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
    Zhang H; Liu S; Tang L; Ge J; Lu X
    Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
    Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
    Zhang R; Xia T
    Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel-like factor 4.
    Zhang W; Wang Q; Du H; Jiang S
    Bioengineered; 2022 Mar; 13(3):6678-6687. PubMed ID: 34696664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity.
    Li Z; Wang Y; Hu R; Xu R; Xu W
    Cell Prolif; 2018 Dec; 51(6):e12504. PubMed ID: 30182452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA
    Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X
    Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
    Suo ST; Gong P; Peng XJ; Niu D; Guo YT
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling.
    Ning Y; Bai Z
    Cancer Biomark; 2021; 30(1):29-39. PubMed ID: 32865178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis.
    Peng J; Yu ZT; Xiao RJ; Wang QS; Xia Y
    Metab Brain Dis; 2022 Mar; 37(3):677-688. PubMed ID: 35088289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
    Deng B; Pan R; Ou X; Wang T; Wang W; Nie Y; Chen H
    Biomed Res Int; 2021; 2021():5271291. PubMed ID: 33816613
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 34. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.
    Fu D; Lu C; Qu X; Li P; Chen K; Shan L; Zhu X
    Aging (Albany NY); 2019 Oct; 11(19):8374-8385. PubMed ID: 31600142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis.
    Zhang H; Yu Y; Wang J; Han Y; Ren T; Huang Y; Chen C; Huang Q; Wang W; Niu J; Lou J; Guo W
    Cancer Cell Int; 2021 Apr; 21(1):192. PubMed ID: 33794884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.